CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Lin Shen, Michelle Frances Morris et al.|Nature Medicine|2025Cited by 29
Deciphering tumor-infiltrating dendritic cells in the single-cell eraQingyu Huang, Chao Liu, Fuhao Wang et al.|Experimental Hematology and Oncology|2023Cited by 22